Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
5.84
-0.08 (-1.35%)
At close: Aug 12, 2026, 4:00 PM EDT
5.84
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:10 PM EDT
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of $859.64 million as of August 12, 2026. Its market cap has increased by 383.86% in one year.
Market Cap
859.64M
Enterprise Value
690.87M
1-Year Change
383.86%
Ranking
Category
Stock Price
$5.84
ChartMarket Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from $214.45M to $859.64M, an increase of 300.85%. That is a compound annual growth rate of 13.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 859.64M | 163.60% |
| Dec 31, 2025 | 326.12M | 22.88% |
| Dec 31, 2024 | 265.41M | 256.83% |
| Dec 29, 2023 | 74.38M | -92.92% |
| Dec 30, 2022 | 1.05B | 17.97% |
| Dec 31, 2021 | 890.25M | 220.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 922.50M |
| Design Therapeutics | 914.94M |
| Olema Pharmaceuticals | 912.60M |
| Kura Oncology | 881.53M |
| Theravance Biopharma | 878.47M |
| Annexon | 874.92M |
| DBV Technologies | 834.54M |
| Aura Biosciences | 833.79M |